D.A. Davidson & CO. Takes $1.71 Million Position in iShares U.S. Pharmaceuticals ETF $IHE

D.A. Davidson & CO. acquired a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 20,148 shares of the company’s stock, valued at approximately $1,709,000.

Other hedge funds also recently modified their holdings of the company. Mather Group LLC. bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the 3rd quarter valued at about $38,000. Assetmark Inc. grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 203.9% in the 4th quarter. Assetmark Inc. now owns 465 shares of the company’s stock valued at $39,000 after acquiring an additional 312 shares in the last quarter. Ameriflex Group Inc. grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% in the 3rd quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock valued at $42,000 after acquiring an additional 291 shares in the last quarter. National Bank of Canada FI grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 42.7% in the 3rd quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after acquiring an additional 175 shares in the last quarter. Finally, NBC Securities Inc. grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 46.5% in the 4th quarter. NBC Securities Inc. now owns 630 shares of the company’s stock valued at $53,000 after acquiring an additional 200 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of NYSEARCA IHE opened at $88.00 on Friday. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $62.02 and a fifty-two week high of $92.29. The stock has a market capitalization of $950.40 million, a price-to-earnings ratio of 17.75 and a beta of 0.49. The business has a 50-day moving average of $87.34 and a 200-day moving average of $84.76.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.